Analysis: The floating profit for the highest private placement participant in BIO has reached 92 times, while the lowest floating profit in the public offering is nearly 15 times.

BlockBeats news, on December 30, according to analysis by ai_9684xtpa, BIO Protocol has raised $30.2 million in funding: Two rounds of private placement, raising a total of $2.3 million, with valuations of $35 million and $69 million respectively; Three rounds of public offering (i.e., BIO Genesis auction), raising a total of $27.9 million, with valuations of $85 million / $142 million / $219 million in the three rounds.

Currently, BIO has been listed for pre-market trading on Bybit and Bitget. Based on the pre-market average price of $0.9659 at 22:00 on December 12, the BIO FDV is approximately $3.2 billion. Private investors: account for 13.60% of the total supply; Public investors: account for 20.00% of the total supply. The costs are as follows:

Private placement · Pre-seed round: Cost approximately $0.01054, current floating profit 91.62 times; · Seed round: Cost approximately $0.02078, current floating profit 46.48 times; Public offering · Round 1: Cost approximately $0.0256, current floating profit 37.73 times; · Round 2: Cost approximately $0.04277, current floating profit 22.58 times; · Round 3: Cost approximately $0.06596, current floating profit 14.64 times.